Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases

NCT04922736 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT04922736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 7, 2021
Completion date
June 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, morphea, scleroderma, systemic